Aug 2026· Frontiers in Bioinformatics· Vol 6· 0 citations· 32 references
Medicine
TL;DR
GATROF provides a new integrated predictive framework for predicting potential microbe–drug associations by combining heterogeneous biological information, GAT-based topological representation learning, and Rotation Forest classification, and may help prioritize candidate drug–microbe associations for further biological validation.
Abstract
Background In recent years, with the diversification and expansion of drug research in the medical field, the widespread use of drugs, particularly antibiotics, has led to increased microbial resistance. Consequently, exploring potential associations between drugs and microbes has become critically important. However, traditional biological experiments are extremely expensive and time-consuming. Therefore, developing more effective computational models for predicting potential associations between microbes and drugs is both essential and challenging. Results We proposed GATROF, a hybrid heterogeneous graph-based framework for microbe–drug association prediction. In GATROF, by integrating multiple microbe–drug–disease similarity measures, we first constructed two distinct microbe–drug networks. In addition, based on different features of microbes and drugs, we further constructed two novel microbe–drug feature matrices. On this basis, the microbe–drug networks and the constructed feature matrices were further used in a Graph Attention Network to learn complementary topology-aware representations of microbes and drugs. These GAT-derived representations were then integrated with the constructed drug-side and microbe-side feature matrices and input into a Rotation Forest classifier for final association prediction. Experimental results and case studies demonstrated that GATROF predicts microbe–drug associations more accurately than existing state-of-the-art methods. Conclusion GATROF provides a new integrated predictive framework for predicting potential microbe–drug associations. By combining heterogeneous biological information, GAT-based topological representation learning, and Rotation Forest classification, GATROF may help prioritize candidate drug–microbe associations for further biological validation.
This work proposes Drug-disease association prediction model (KNN, GIN, Graph Transformer and Cross-attention, KGTC-DDA), a novel framework that combines Graph Isomorphism Networks (GIN), Graph Transformers, and cross-attention mechanisms for drug-disease association prediction.
Jia-Hao Chen, Zi Liu, Li-Yi Yu et al.· Biochemistry and Biophysics...· 0 citations
IHLO-DTI, a novel prediction model based on an improved hypergraph neural network and Laplacian matrix optimization, can effectively capture high-order many-to-many interactions between drugs and targets, improving prediction accuracy and robustness.
Guolongwei Dai, Tao Luo, Dan-Dan Li et al.· ACS Synthetic Biology· 0 citations
Drug repurposing and target discovery offer critical strategies for advancing therapeutic development by uncovering the potential biological pathways and novel associations among drugs, genes, and diseases. However, experimental discovery remains expensive and time-consuming, which limits the scalability of large-scale...
Hong-Sheng Xie, Yuan Gao, Shan-Lin Ke et al.· bioRxiv· 0 citations
Results indicate that FragSyn, through the synergistic design of fragment-level representation and cellular context awareness, provides an effective and interpretable new approach to synergistic drug combination prediction.
Li-Feng Shao, Jianqiang Sun, Hong-Zhan Ma et al.· Journal of Chemical Informat...· 0 citations
Case studies further validated predicted circRNA-drug associations, including cisplatin, enzalutamide, and sorafenib, against published experimental findings, demonstrating HMCDSP's capacity to reveal clinically relevant biomarkers and inform personalized therapeutic strategies.
Yong-Tian Wang, Wen-Kai Shen, Jiahao Li et al.· Interdisciplinary Sciences C...· 1 citation
This review systematically analyzes key challenges in DDI prediction: balancing model performance with interpretability, integrating heterogeneous features, ensuring sample set reliability, and optimizing algorithmic architectures, and outlines promising directions for future innovation.
Yun Zuo, Jia-Yi Ji, Yuwen Li et al.· Current Bioinformatics· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.